Neuroimaging studies of the early stages of psychosis: A critical review

European Psychiatry

Volumn 23, Issue 4, 2008, Pages 237-244

  Fusar Poli, Paolo ^a,b   Allen, Paul ^a   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Functional magnetic resonance imaging; Neuroimaging; Psychosis

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; RISPERIDONE;

ARTICLE; BEHAVIOR; CLINICAL FEATURE; CLINICAL TRIAL; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LOW DRUG DOSE; MEDICAL RESEARCH; NEUROIMAGING; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; BRAIN; CHILD; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MULTICENTER STUDIES AS TOPIC; NERVE NET; PSYCHOTIC DISORDERS; SENSITIVITY AND SPECIFICITY;

EID: 44849123860     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.03.008     Document Type: Article

References (74)

1. Agid O., Kapur S., Arenovich T., and Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry 60 (2003) 1228-1235
2. Aguirre G.K., Singh R., and D'Esposito M. Stimulus inversion and the responses of face and object-sensitive cortical areas. Neuroreport 10 (1999) 189-194
3. Almli C.R., Rivkin M.J., and McKinstry R.C. The NIH MRI study of normal brain development (Objective-2): newborns, infants, toddlers, and preschoolers. Neuroimage 35 (2007) 308-325
4. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald III A., Noll D.C., et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58 (2001) 280-288
5. Brett M., Johnsrude I.S., and Owen A.M. The problem of functional localization in the human brain. Nat Rev Neurosci 3 (2002) 243-249
6. Boksman K., Theberge J., Williamson P., Drost D.J., Malla A., Densmore M., et al. A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr Res 75 (2005) 247-263
7. Braus D.F., Ende G., Weber-Fahr W., Sartorius A., Krier A., Hubrich-Ungureanu P., et al. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr Res 39 (1999) 19-29
8. Broome M.R., Johns L.C., and Woolley J.B. The data-gathering bias in the at-risk mental state (ARMS) for psychosis. Schizophr Res 70 (2004) 100-101
9. Buchanan R.W., and Carpenter W.T. Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia. J Nerv Ment Dis 182 (1994) 193-204
10. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10 (2000) 1078-1092
11. Callicott J.H., Egan M.F., Mattay V.S., Bertolino A., Bone A.D., Verchinksi B., et al. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160 (2003) 709-719
12. Chakos M.H., Schobel S.A., Gu H., Gerig G., Bradford D., Charles C., et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br J Psychiatry 186 (2005) 26-31
13. Chang C.J., Chen W.J., Liu S.K., Cheng J.J., Yang W.C., Chang H.J., et al. Morbidity risk of psychiatric disorders among the first degree relatives of schizophrenia patients in Taiwan. Schizophr Bull 28 (2002) 379-392
14. Curtis V.A., Bullmore E.T., Brammer M.J., Wright I.C., Williams S.C., Morris R.G., et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 155 (1998) 1056-1063
15. Dazzan P., Morgan K.D., Orr K., Hutchinson G., Chitnis X., Suckling J., et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology 30 (2005) 765-774
16. Detre J.A. Clinical applicability of functional MRI. J Magn Reson Imaging 23 (2006) 808-815
17. Dickey C.C., McCarley R.W., and Shenton M.E. The brain in schizotypal personality disorder: a review of structural MRI and CT findings. Harv Rev Psychiatry 10 (2002) 1-15
18. Evans A.C. The NIH MRI study of normal brain development. Neuroimage 30 (2006) 184-202
19. Fleiss J.L. The statistical basis of meta-analysis. Stat Methods Med Res 2 (1993) 121-145
20. Fox P.T., Laird A.R., Fox S.P., Fox P.M., Uecker A.M., Crank M., et al. BrainMap taxonomy of experimental design: description and evaluation. Hum Brain Mapp 25 (2005) 185-198
21. Fox P.T., Laird A.R., and Lancaster J.L. Coordinate-based voxel-wise meta-analysis: dividends of spatial normalization. Report of a virtual workshop. Hum Brain Mapp 25 (2005) 1-5
22. Frith C. The neural basis of hallucinations and delusions. C R Biol 328 (2005) 169-175
23. Fusar-Poli P., and Borgwardt S. Integrating the negative psychotic symptoms in the high-risk criteria for the prediction of psychosis. Med Hyp 69 4 (2007) 959-960
24. Fusar-Poli P., and Broome M.R. Conceptual issues in psychiatric neuroimaging. Curr Opin Psychiatry 19 (2006) 608-612
25. Fusar-Poli P., Broome M., Matthiasson P., Williams S., Brammer M., and McGuire P. Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study. Eur Neuropsychopharmacol 187 4 (2007) 486-497
26. Fusar-Poli P., Caverzasi E., and Cortesi M. Pooling of data in psychiatric neuroimaging: a bridge towards clinical neuroimaging?. Eur Psychiatry May 22 4 (2007) 265
27. Fusar-Poli P., Perez J., Broome M., Borgwardt S., Placentino A., Caverzasi E., et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev 31 4 (2007) 465-484
28. Habel U., Klein M., Shah N.J., Toni I., Zilles K., Falkai P., et al. Genetic load on amygdala hypofunction during sadness in nonaffected brothers of schizophrenia patients. Am J Psychiatry 161 (2004) 1806-1813
29. Harvey P.D., Rabinowitz J., Eerdekens M., and Davidson M. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry 162 (2005) 1888-1895
30. Honey G.D., Bullmore E.T., Soni W., Varatheesan M., Williams S.C., and Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 96 (1999) 13432-13437
31. Hopfinger J.B., Buchel C., Holmes A.P., and Friston K.J. A study of analysis parameters that influence the sensitivity of event-related fMRI analyses. Neuroimage 11 (2000) 326-333
32. Jablensky A., and Kendell R. Criteria for assessing a classification in psychiatry. In: Maj M., Gaebel W., Lopez-Ibor J., and Sartorius N. (Eds). Psychiatric diagnosis and classification (2002), Wiley, Chichester 1-25
33. Jansson L., Handest P., Nielsen J., Sæbye D., and Parnas J. Exploring boundaries of schizophrenia: a comparison of ICD-10 with other diagnostic systems in first-admitted patients. Wordl Psych 1 (2002) 109-114
34. Johnson J.K., Tuulio-Henriksson A., Pirkola T., Huttunen M.O., Lonnqvist J., Kaprio J., et al. Do schizotypal symptoms mediate the relationship between genetic risk for schizophrenia and impaired neuropsychological performance in co-twins of schizophrenic patients?. Biol Psychiatry 54 (2003) 1200-1204
35. Johnstone E.C., Crow T.J., Frith C.D., Husband J., and Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2 (1976) 924-926
36. Kapur S., Arenovich T., Agid O., Zipursky R., Lindborg S., and Jones B. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry 162 (2005) 939-946
37. Keshavan M.S., Montrose D.M., Pierri J.N., Dick E.L., Rosenberg D., Talagala L., et al. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 21 (1997) 1285-1295
38. Kopala L.C., Good K.P., Milliken H., Buiteman C., Woodley H., Rui Q., et al. Treatment of a first episode of psychotic illness with quetiapine: an analysis of 2 year outcomes. Schizophr Res 81 (2006) 29-39
39. Lahti A.C., Holcomb H.H., Weiler M.A., Medoff D.R., Frey K.N., Hardin M., et al. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29 (2004) 171-178
40. Lane C.J., Ngan E.T., Yatham L.N., Ruth T.J., and Liddle P.F. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia. J Psychiatry Neurosci 29 (2004) 30-37
41. Mendrek A., Kiehl K.A., Smith A.M., Irwin D., Forster B.B., and Liddle P.F. Dysfunction of a distributed neural circuitry in schizophrenia patients during a working-memory performance. Psychol Med 35 (2005) 187-196
42. Mendrek A., Laurens K.R., Kiehl K.A., Ngan E.T., Stip E., and Liddle P.F. Changes in distributed neural circuitry function in patients with first-episode schizophrenia. Br J Psychiatry 185 (2004) 205-214
43. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 159 (2002) 863-865
44. Morey R.A., Inan S., Mitchell T.V., Perkins D.O., Lieberman J.A., and Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry 62 (2005) 254-262
45. Ngan E.T., Lane C.J., Ruth T.J., and Liddle P.F. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naive schizophrenic patients: correlations with symptom change. J Neurol Neurosurg Psychiatry 72 (2002) 106-110
46. Olsen K., and Rosenbaum R.S. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 113 (2006) 247-272
47. Pantelis C., Yucel M., Wood S.J., Velakoulis D., Sun D., Berger G., et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 31 (2005) 672-696
48. Perlstein W.M., Carter C.S., Noll D.C., and Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 158 (2001) 1105-1113
49. Racine E., Bar-Ilan O., and Illes J. fMRI in the public eye. Nat Rev Neurosci 6 (2005) 159-164
50. Ramsey N.F., Koning H.A., Welles P., Cahn W., van der Linden J.A., and Kahn R.S. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain 125 (2002) 1793-1807
51. Rasser P.E., Johnston P., Lagopoulos J., Ward P.B., Schall U., Thienel R., et al. Functional MRI BOLD response to Tower of London performance of first-episode schizophrenia patients using cortical pattern matching. Neuroimage 26 (2005) 941-951
52. Riehemann S., Volz H.P., Stutzer P., Smesny S., Gaser C., and Sauer H. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test-a fMRI study. Eur Arch Psychiatry Clin Neurosci 251 (2001) 66-71
53. Roland P., Svensson G., Lindeberg T., Risch T., Baumann P., Dehmel A., et al. A database generator for human brain imaging. Trends Neurosci 24 (2001) 562-564
54. Schaufelberger M., Senhorini M.C., Barreiros M.A., Amaro Jr. E., Menezes P.R., Scazufca M., et al. Frontal and anterior cingulate activation during overt verbal fluency in patients with first episode psychosis. Rev Bras Psiquiatr 27 (2005) 228-232
55. Schnack H.G., van Haren N.E., Hulshoff Pol H.E., Picchioni M., Weisbrod M., Sauer H., et al. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Hum Brain Mapp 22 (2004) 312-320
56. Seidman L.J., Thermenos H.W., Poldrack R., Peace N., Koch J., Faraone S.V., et al. Altered brain activation in frontal cortex in adolescents and young adults at genetic risk for schizophrenia: an fMRI study of working memory. Schizophr Res 85 (2006) 58-72
57. Siever L.J., Koenigsberg H.W., Harvey P., Mitropoulou V., Laruelle M., Abi-Dargham A., et al. Cognitive and brain function in schizotypal personality disorder. Schizophr Res 54 (2002) 157-167
58. Snitz B.E., Macdonald III A., Cohen J.D., Cho R.Y., Becker T., and Carter C.S. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162 (2005) 2322-2329
59. Steen R.G., Hamer R.M., and Lieberman J.A. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30 (2005) 1949-1962
60. Steen R.G., Mull C., McClure R., Hamer R.M., and Lieberman J.A. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188 (2006) 510-518
61. Stocker T., Schneider F., Klein M., Habel U., Kellermann T., Zilles K., et al. Automated quality assurance routines for fMRI data applied to a multicenter study. Hum Brain Mapp 25 (2005) 237-246
62. Strother S., La Conte S., Kai Hansen L., Anderson J., Zhang J., Pulapura S., et al. Optimizing the fMRI data-processing pipeline using prediction and reproducibility performance metrics: I. A preliminary group analysis. Neuroimage 23 Suppl 1 (2004) S196-S207
63. Talairach J., and Tournoux P. A co-planar stereotactic atlas of the human brain (1988), Thieme Medical Publishers, New York
64. Tan H.Y., Choo W.C., Fones C.S., and Chee M.W. fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia. Am J Psychiatry 162 (2005) 1849-1858
65. Tauscher J., Jones C., Remington G., Zipursky R.B., and Kapur S. Significant dissociation of brain and plasma kinetics with antipsychotics. Mol Psychiatry 7 (2002) 317-321
66. Tsuang M.T., Stone W.S., and Faraone S.V. Understanding predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry 47 (2002) 518-526
67. Van Horn J.D., and Gazzaniga M.S. Opinion: databasing fMRI studies towards a 'discovery science' of brain function. Nat Rev Neurosci 3 (2002) 314-318
68. Van Horn J.D., Grafton S.T., Rockmore D., and Gazzaniga M.S. Sharing neuroimaging studies of human cognition. Nat Neurosci 7 (2004) 473-481
69. Vita A., De Peri L., Silenzi C., and Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82 (2006) 75-88
70. Ward P.B. Structural brain imaging and the prevention of schizophrenia: can we identify neuroanatomical markers for young people at risk for the development of schizophrenia?. Aust N Z J Psychiatry 34 Suppl (2000) S127-S130
71. Whalley H.C., Simonotto E., Flett S., Marshall I., Ebmeier K.P., Owens D.G., et al. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain 127 (2004) 478-490
72. Whalley H.C., Simonotto E., Marshall I., Owens D.G., Goddard N.H., Johnstone E.C., et al. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain 128 (2005) 2097-2108
73. Yung A.R., and McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22 (1996) 353-370
74. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., et al. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 60 (2003) 21-32